ClinicalTrials.Veeva

Menu

Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

Fred Hutchinson Cancer Center (FHCC) logo

Fred Hutchinson Cancer Center (FHCC)

Status

Enrolling

Conditions

Hematopoietic and Lymphatic System Neoplasm

Treatments

Dietary Supplement: Kate Farms 1.0
Procedure: Biospecimen Collection
Other: Fiber and Dietary Assessments
Dietary Supplement: Dietary Supplement
Other: Electronic Health Record Review
Dietary Supplement: Standard of Care Nutritional Support
Other: Survey Administration

Study type

Interventional

Funder types

Other

Identifiers

NCT04829136
RG1121363
NCI-2021-00842 (Registry Identifier)
10599

Details and patient eligibility

About

This clinical trial examines sustained oral fiber supplementation for patients undergoing donor stem cell transplantation for hematological malignancies. Patients undergoing donor stem cell transplantation often develop oral and gastrointestinal damage from chemotherapy, radiotherapy, or graft-versus-host disease. Oral fiber nutrition support may improve overall nutrition, support a normal gut microbiome (bacteria that live in the gut) and/or improve gut function in patients undergoing stem cell transplants.

Full description

OUTLINE:

Current study design: Patients receive fiber supplementation orally (PO) or enterally starting 14 to 5 days prior to standard of care conditioning chemotherapy and continuing until discharge. Patients who are not able to receive sufficient nutrition by mouth may receive parenteral nutrition or enteral nutrition by feeding tube from the hospital. Patients may undergo blood sample collection throughout the study.

Previous study design: Before this study was amended in January 2024, patients were randomized to 1 of 2 arms.

Previous Arm I: Patients received enteral nutrition via nasoenteric feeding tube starting on day 1 until hospital discharge.

Previous Arm II: Patients received standard of care nutritional support.

After completion of study treatment, patients are followed up at days 42, 60 and 90 days post transplant.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Able to provide written informed consent prior to initiation of any study procedures
  • Planned allogeneic stem cell transplantation
  • At least 18 years of age

Exclusion criteria

  • Major psychiatric diagnosis that impairs cognitive functioning or is not controlled at the time of the approach, as judged by the patient's medical team
  • Pregnant or breastfeeding. Pregnancy test is obtained as part of pre-transplant evaluation in women of child-bearing potential at arrival to transplant and again within 7 days of conditioning and will be confirmed as negative by review of the chart

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 3 patient groups

Arm I (enteral nutrition) [Discontinued in January 2024]
Experimental group
Description:
Patients receive enteral nutrition via nasoenteric feeding tube starting on day 1 until hospital discharge.
Treatment:
Other: Survey Administration
Dietary Supplement: Kate Farms 1.0
Arm II (standard of care) [Discontinued in January 2024]
Active Comparator group
Description:
Patients receive standard of care nutritional support.
Treatment:
Other: Survey Administration
Dietary Supplement: Standard of Care Nutritional Support
Supportive care (Fiber) [Current study activity]
Experimental group
Description:
Patients receive fiber supplementation PO or enterally starting 14 to 5 days prior to standard of care conditioning chemotherapy and continuing until discharge from the hospital. Stool will be collected at different time points throughout the study. Patients may also undergo blood sample collection throughout the study.
Treatment:
Other: Survey Administration
Other: Electronic Health Record Review
Dietary Supplement: Dietary Supplement
Other: Fiber and Dietary Assessments
Procedure: Biospecimen Collection

Trial contacts and locations

1

Loading...

Central trial contact

David Fredricks

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems